
Blood Cancer Research Confirms CEBPA Gene Mutation Cuts Survival from 31 to 15 Months in MDS-AML Progression
Scientists at the University of Birmingham have developed a powerful new breakthrough lab model that could speed up the search for treatments for an aggressive blood cancer, according to research published in